Adipose-Derived Stem Cell Senescence Research Program
exploratoryresearch program · medium
Understand and characterize replicative and stressor-induced senescence in human adipose-derived mesenchymal stem cells to support standards, potency measures, and therapeutic development for aging-related applications.
Senescence assays using stem cell immunophenotype, proliferation rate, migration potential, secretory and immunomodulatory profiling, microRNA target analysis, and related cellular senescence markers.
Multiple filtered publications from 2017-2019 describe hADSC senescence methods, senescence-associated microRNAs, and MSC senescence secretome and immunomodulation biology.
Publications report methodological frameworks for hADSC senescence characterization and describe roles for senescence-associated microRNAs and secretory responses in MSC biology.
Aelan Stem Cell Clinical Program
undisclosedresearch program · high
Develop stem-cell-based biomedical technologies for human health and longevity, including potential clinical applications of adipose-derived mesenchymal stem cells in regenerative medicine, dermatology, skin aging, wound healing, and tissue repair.
Human adipose-derived mesenchymal stem/stromal cell procurement, isolation, culture, differentiation, characterization, and assessment of senescence-related potency markers.
Aelan identifies Meenakshi Gaur, PhD as Director, Stem Cell Clinical Program, and the site states that stem cell expert Dr. Gaur joined the team.
Published work describes protocols and assays for adipose-derived mesenchymal stem cells and reviews clinical applications in dermatology and skin aging; no Aelan clinical trial result is supplied.
Alzheimer's Biomarker Program
undisclosedbiomarker · low
Investigate or develop an Alzheimer's disease biomarker within Aelan's diagnostics and longevity-oriented biomedical technology activities.
Biomarker or molecular diagnostic approach; supplied material does not describe the assay, analyte, cohort, or validation design.
The supplied site analysis includes Alzheimer's biomarker among Aelan disambiguation keywords, but no detailed pipeline entry or publication result is provided.
IL-2-Primed Adipose-Derived Mesenchymal Stem Cell Research
exploratoryresearch program · medium
Study how interleukin-2 priming changes human adipose-derived mesenchymal stem cell responses and how replicative senescence affects those responses.
Transcriptional profiling of interleukin-2-primed human adipose-derived mesenchymal stem cells, comparing responses under replicative senescence.
A filtered publication reports transcriptional profiling of IL-2-primed human adipose-derived mesenchymal stem cells and senescence-imposed response changes.
The supplied publication title states that IL-2 priming and replicative senescence produced dramatic changes in stem-cell response; detailed results are not fully supplied.
Molecular Diagnostics Program
undisclosedbiomarker · medium
Develop diagnostics and biomarker-related technologies as part of Aelan's biomedical technology portfolio for human health and longevity.
Molecular diagnostics program; supplied material does not specify the assay format or clinical validation method.
Aelan identifies James Tollervey, PhD as Director, Molecular Diagnostics, and the site analysis describes diagnostics as a primary approach.
